These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7074164)

  • 1. [NMR relaxation in human blood serum a cancer diagnostic method].
    Revokatov OP; Gangardt MG; Murashko VV; Zhuravlev AK
    Biofizika; 1982; 27(2):336-8. PubMed ID: 7074164
    [No Abstract]   [Full Text] [Related]  

  • 2. [Assessment of the feasibility of using the time of NMR spin-lattice relaxation in blood serum for the diagnosis of cancer].
    Galil-Ogly GA; Dmitriev GI; Koriakina NF; Bozhenko VK; Kalachikhina OD
    Vestn Akad Med Nauk SSSR; 1987; (12):43-6. PubMed ID: 3445698
    [No Abstract]   [Full Text] [Related]  

  • 3. [The measurement of NMR-1H relaxation time of blood serum as a method of laboratory diagnosis].
    Baĭkeev RF; Khaĭrullina VR; Ziatdinov KM; Mazitova FM; Mavliutova RI
    Lab Delo; 1990; (12):17-9. PubMed ID: 1710685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [NMR-relaxation of blood serum in cancer patients].
    Papish EA; Temkina TIa; Kariakina NF
    Med Radiol (Mosk); 1988 Aug; 33(8):47-50. PubMed ID: 3412139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A method of NMR-relaxometry of the blood serum applicable to the diagnosis of malignant neoplasms].
    Papish EA; Kariakina NF
    Vestn Akad Med Nauk SSSR; 1989; (7):74-81. PubMed ID: 2683466
    [No Abstract]   [Full Text] [Related]  

  • 6. [Proton NMR-relaxation of nonaqueous components of human blood serum].
    Gangardt MG; Kariakina NF; Pavlov AS; Papish EA
    Biull Eksp Biol Med; 1995 Oct; 120(10):445-8. PubMed ID: 8595245
    [No Abstract]   [Full Text] [Related]  

  • 7. Can NMR of a blood sample detect cancer or not?
    Oncology (Williston Park); 1990 Oct; 4(10):12, 15. PubMed ID: 2149822
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nuclear magnetic resonance of plasma? A method for the diagnostic and therapeutic control of cancer?].
    Sezer O; Rasche H; Stelten J; Leibfritz D
    Dtsch Med Wochenschr; 1988 Apr; 113(17):705-6. PubMed ID: 3359939
    [No Abstract]   [Full Text] [Related]  

  • 9. Magnetic resonance spectroscopy of blood plasma lipoproteins in malignant disease: methodological aspects and clinical relevance.
    Engan T
    Anticancer Res; 1996; 16(3B):1461-71. PubMed ID: 8694514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear magnetic resonance study of cancer: systemic effect on the proton relaxation times (T1 and T2) of human serum.
    de Certaines J; Bernard AM; Benoist L; Rivet P; Gallier J; Morin P
    Cancer Detect Prev; 1981; 4(1-4):267-71. PubMed ID: 7349785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear relaxation in serum protein mixtures and serum samples.
    Olszewski KJ; Baranowska HM
    Physiol Chem Phys Med NMR; 1993; 25(2):83-7. PubMed ID: 8397425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR--another cancer-test disappointment.
    Shulman R
    N Engl J Med; 1990 Apr; 322(14):1002-3. PubMed ID: 2314436
    [No Abstract]   [Full Text] [Related]  

  • 13. Nuclear magnetic resonance imaging: methods and current status.
    Katims LM
    Med Instrum; 1982; 16(4):213-6. PubMed ID: 7132825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical dilemmas in the early detection of malignancy by NMR spectroscopy of plasma.
    Shaw A
    N Engl J Med; 1987 Nov; 317(21):1353. PubMed ID: 3683466
    [No Abstract]   [Full Text] [Related]  

  • 15. 1H-NMR spectroscopy in aqueous mediums. Examination of experimental conditions with human urine as a model sample.
    Yoshikawa K; Matsushita K; Ohsaka A
    Physiol Chem Phys; 1982; 14(4):385-9. PubMed ID: 7186135
    [No Abstract]   [Full Text] [Related]  

  • 16. [Proton-magnetic resonance spectroscopy (1H-MRS) of human plasma obtained from patients with various cancer--new detection method for common cancer].
    Itoh YH; Kikuchi A; Kobayashi M; Oguri T
    Rinsho Byori; 1995 Dec; 43(12):1279-83. PubMed ID: 8569041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR relaxation time studies of large bowel neoplasms.
    Kowalski P; Skupin P; Sowier J; Olszewski KJ
    Physiol Chem Phys Med NMR; 1997; 29(1):51-4. PubMed ID: 9353957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR-based metabolomics approach to target biomarkers for human prostate cancer.
    Jordan KW; Cheng LL
    Expert Rev Proteomics; 2007 Jun; 4(3):389-400. PubMed ID: 17552923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of combined use of serum tumour markers and nuclear magnetic spectroscopy of plasma in the detection of pancreatic cancer among patients with jaundice or cholestasis: results from a prospective study.
    Pasanen PA; Kauppinen R; Eskelinen M; Partanen K; Pikkarainen P; Alhava E
    Anticancer Res; 1993; 13(3):763-8. PubMed ID: 8317910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: towards personalized medicine.
    Anderson JE; Hansen LL; Mooren FC; Post M; Hug H; Zuse A; Los M
    Drug Resist Updat; 2006; 9(4-5):198-210. PubMed ID: 17011811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.